The global nucleic acid labeling market size is expected to reach USD 3.22 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.81% from 2020 to 2027. Technological advancements with respect to PCR, DNA sequencing, nanotechnology, and microfluidics are expected to help enhance the market potential in the near future. Additionally, nucleic acid labeling products are gaining significant momentum across diagnostic as well as therapeutic interventions associated with cancer disorders and genetic deformities, thereby elevating the market growth.
Technologies
that enable direct detection of specific sequences of RNA or DNA serve as
occasional potent alternatives to amplification protocols employed in gene
expression studies. Research activities performed on these lines have also led
to the development of novel label protocols such as that of incorporating
probes that are specifically labeled with anti-label antibodies conjugated via
alkaline phosphatase. This direct detection technique employing the use of specific
labeled probes has emerged as a reliable and flexible approach for gene
expression analysis, well-suited for high-throughput screening.
The
continuing quest for designing labels with enhanced functional properties
suitable for hybridization assays has led to the introduction of an array of
potential approaches to label nucleic acids that are inclusive of genes
encoding enzymes, microparticles, and a novel class of fluorophores.
With
the emergence of novel viral infections, such as the coronavirus (COVID 19),
followed by the MERS outbreak in 2015 and the SARS outbreak in 2003, healthcare
professionals are experiencing a significant urge for the development of rapid
detection approaches that can assist in the identification of target viruses at
scale. The COVID-19 pandemic has also led to an increase in demand for nucleic
acid-based research efforts aimed at developing breakthrough treatment
solutions, further expected to accelerate market expansion.
Full Research Report On Nucleic Acid Labeling Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/nucleic-acid-labeling-market
Nucleic Acid
Labeling Market Report Highlights
- By product, the reagents
segment dominated the market in 2019 and is set to maintain its lead
throughout the forecast period. This is attributed to the fact that
reagents are essential components across both enzymatic and chemical
labeling, resulting in an expanding vendor base aimed at introducing novel
and effective reagents to label DNA/RNA
- By labeling type, the
radioactive or radioisotope labels dominated the market in 2019 and are
anticipated to maintain their lead throughout the forecast period.
Radioactive labeling is gaining increased traction among the
professionals, which is further supplemented by the ease of incorporation
of radioactively labeled nucleic acid sequences
- The oligonucleotide
application segment is expected to grow at the fastest pace from 2020 to
2027. The end labeling of oligonucleotides with radioisotopes has gained
immense traction over the years. This is attributed to the fact that such
oligonucleotides are set to drive the nucleic acid probe technology, which
can be custom made via the information on target RNA and DNA
- North America captured the
largest share of 39.47% in 2019, which is primarily attributed to the
expanding portfolios of emerging manufacturers, along with robust support
from research organizations, collectively contributing to the regional
revenue
- Companies are engaged in
acquisitions and collaborations to maintain a competitive edge in the
market
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/nucleic-acid-labeling-market/request/rs1
Nucleic Acid
Labeling Market Segmentation
Grand View Research has segmented
the global nucleic acid labeling market on the basis of product, labeling type,
method, application, sector, and region:
Nucleic Acid
Labeling Product Outlook (Revenue, USD Million, 2016 - 2027)
- Kits
- Reagents
- Instruments
Nucleic Acid
Labeling Type Outlook (Revenue, USD Million, 2016 - 2027)
- Radioisotope/Radioactive
Labels
- Non-radioactive Labels
Nucleic Acid
Labeling Method Outlook (Revenue, USD Million, 2016 - 2027)
- Enzyme-based
- PCR
- 5' end labeling
- 3' end labeling
- Others
- Chemical-based
- Conjugation
- Photoreaction
Nucleic Acid
Labeling Application Outlook (Revenue, USD Million, 2016 - 2027)
- Oligonucleotide Labeling
- In-situ Hybridization
- Southern & Northern
Blotting
- Cellular Localization
- Others
Nucleic Acid
Labeling Sector Outlook (Revenue, USD Million, 2016 - 2027)
- Diagnostics
- Research
- Therapeutics
Nucleic Acid
Labeling Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Middle East Africa (MEA)
- South Africa
List of Key Players
of Nucleic Acid Labeling Market
- PerkinElmer, Inc.
- F. Hoffmann La-Roche AG
- Cytiva
- Thermo Fisher Scientific
Inc.
- Promega Corporation
- New England Biolabs
- Enzo Biochem, Inc.
- Vector Laboratories
- Agilent Technologies
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment